Frank J. Williams - 09 Jul 2021 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Executive Chairman, Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
09 Jul 2021
Net transactions value
-$151,101
Form type
4
Filing time
13 Jul 2021, 21:27:19 UTC
Previous filing
21 Jun 2021
Next filing
21 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Sale $82,432 -3,584 -0.53% $23.00 671,494 09 Jul 2021 Direct F1, F2
transaction EVH Class A Common Stock Options Exercise $13,763 +3,584 +0.53% $3.84* 675,078 09 Jul 2021 Direct F1, F2
transaction EVH Class A Common Stock Sale $82,432 -3,584 -0.53% $23.00 671,494 09 Jul 2021 Direct F1, F2
holding EVH Class A Common Stock 66,064 09 Jul 2021 See Footnote. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -3,584 -0.5% $0.000000 712,976 09 Jul 2021 Class A Common Stock 3,584 $3.84 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2021.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
F4 The Class A Common Stock Options exercised vested on December 1, 2014.